Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.35
+0.02001.50%
Volume:246.98K
Turnover:330.32K
Market Cap:80.28M
PE:-0.37
High:1.37
Open:1.33
Low:1.30
Close:1.33
Loading ...

IGM Biosciences Inc : RBC Cuts to Sector Perform From Outperform

THOMSON REUTERS
·
10 Jan

IGM Biosciences downgraded to Hold from Buy at Stifel

TIPRANKS
·
10 Jan

IGM Biosciences downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
10 Jan

IGM Biosciences (IGMS) was downgraded to a Sell Rating at Morgan Stanley

TIPRANKS
·
10 Jan

IGM Biosciences downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
10 Jan

IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out

Dow Jones
·
10 Jan

IGM Biosciences to Slash Workforce by 73%, Halt Two Drug Programs, Evaluate Alternatives

MT Newswires Live
·
10 Jan

IGM Biosciences to Halt Development of Imvotamab, Cut 73% of Staff

Dow Jones
·
10 Jan

IGM Biosciences halting further development of imvotamab and IGM-2644

TIPRANKS
·
10 Jan

BRIEF-IGM Biosciences Reduces Its Workforce By 73%

Reuters
·
10 Jan

IGM Biosciences Inc -Company Halting Further Development of Imvotamab (Cd20 X Cd3) and IGM-2644 (Cd38 X Cd3)

THOMSON REUTERS
·
10 Jan

IGM Biosciences Inc - Currently Evaluating Internal Options as Well as Potential Strategic Alternatives

THOMSON REUTERS
·
10 Jan

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

THOMSON REUTERS
·
10 Jan

IGM Biosciences Inc -Company Reducing Its Workforce by 73%

THOMSON REUTERS
·
10 Jan

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

GlobeNewswire
·
10 Jan

BMO Capital Initiates IGM Biosciences at Outperform With $21 Price Target

MT Newswires Live
·
06 Dec 2024